STAT1 Gain-of-Function Disease

1

Review clinical trials related to STAT1 Gain-of-Function Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease

Location

Anywhere

By Last updated

Status: Available

Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease

Expanded access use of Itacitinib to treat a single patient with aplastic anemia.

Trial details

Type: Expanded AccessSponsor: Incyte CorporationUpdated: Jun 10, 2026

Eligibility criteria

Not listed